Quintiles Expands Singapore Operations; Poised To Be Largest CRO In Asia Pacific
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Quintiles Transnational is expanding its Singapore operations in a move that will house the largest clinical development organization in Asia-Pacific
You may also be interested in...
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News (Part 1 of 2)
The world's largest contract research organization, Quintiles Transnational, has been operating in Asia-Pacific region for more than 17 years. Two Quintiles Asia executives, Quintiles India CEO Dr. Ferzaan Engineer and Senior VP and Head of Clinical Development for Quintiles Asia-Pacific Dr. Anand Tharmaratnam, recently shared their views with PharmAsia News on the changing CRO market in the region.
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News (Part 1 of 2)
The world's largest contract research organization, Quintiles Transnational, has been operating in Asia-Pacific region for more than 17 years. Two Quintiles Asia executives, Quintiles India CEO Dr. Ferzaan Engineer and Senior VP and Head of Clinical Development for Quintiles Asia-Pacific Dr. Anand Tharmaratnam, recently shared their views with PharmAsia News on the changing CRO market in the region.
Quintiles Expands Operations In China
SHANGHAI - Quintiles Transnational will move its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing to a larger facility to meet growing demands in China, the company announced Jan. 9